Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Journeycake, Janna
Item TypeName
Concept Hemophilia A
Academic Article Coagulation disorders.
Academic Article Fatal central venous catheter-related infection in haemophilia.
Academic Article Application of current knowledge to the management of bleeding events during immune tolerance induction.
Academic Article Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.
Academic Article Extended half-life factor VIII for immune tolerance induction in haemophilia.
Academic Article Consensus recommendations for use of central venous access devices in haemophilia.
Academic Article Developing a multidisciplinary Young Women's Blood Disorders Program: a single-centre approach with guidance for other centres.
Academic Article Catheter-related deep venous thrombosis in children with hemophilia.
Academic Article Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis.
Academic Article Arthroscopic synovectomy in children and adolescents with hemophilia.
Academic Article Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience.
Academic Article Deep venous thrombosis screening in patients with inherited bleeding disorders and central venous catheters.
Academic Article Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders.
Academic Article PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
Academic Article The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
Academic Article Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.
Search Criteria
  • Hemophilia B